Bonle Technology (301065.SZ): Cumulative repurchase of 2.69% of the shares.

On July 2nd, Gelonhui reported that till June 30th 2024, the company had accumulated 2,847,362 shares of the company through stock repurchase special securities account with centralized bidding trading, accounting for 2.69% of the company's current total share capital; the highest fill price for repurchase is RMB 18.20/share, the lowest fill price is RMB 14.59/share; the total amount of the transaction is RMB 50,002,854.65 (excluding transaction fees). This share repurchase program complies with relevant laws and regulations, as well as the company's share repurchase plan.

Gelonghui FinanceJul 2 06:13 ET

Bonli Technology (301065.SZ): Equity distribution of 10 dividends and 1 yuan in 2023, with a registration date of June 19th.

On June 13th, Glemonews reported that the equity distribution plan for Benli Technology (301065.SZ) in 2023 is: using a total of 103,172,638 shares of the company's existing total share capital, excluding 2,847,362 repurchased shares, distribute RMB 1.000000 cash (tax included) to all shareholders for every 10 shares held. The equity distribution registration date is June 19th, 2024, and the ex-dividend date is June 20th, 2024.

Gelonghui FinanceJun 13 04:55 ET

Benli Technology (301065.SZ) has repurchased 2.69% of its shares at a cost of RMB 50,900

Benli Technology (301065.SZ) announced that as of May 31, 2024, the company has passed a share repurchase exclusive...

Zhitong FinanceJun 3 03:59 ET

Chen Qian, a shareholder of Benli Technology (301065.SZ), completed a total reduction of 765,000 shares

Benli Technology (301065.SZ) announced that Chen Qian, the unanimous actor of Jiang Huajiang, the shareholder holding more than 5% of the company's shares, reduced his holdings...

Zhitong FinanceMay 20 06:16 ET

Benli Technology (301065.SZ): Existing products are mainly used in medicine, pesticides and other fields

Gelonghui, May 20 | Benli Technology (301065.SZ) said on the investor interactive platform that the company's current products are mainly used in medicine, pesticides and other fields. The company's current business situation is stable and orderly, and there are plenty of orders in hand, which can guarantee the company's sustainable and healthy development.

Gelonghui FinanceMay 20 04:21 ET

Benli Technology (301065.SZ): The company's existing products and technologies have not yet involved the field of synthetic biology

Gelonghui, May 8, 丨 Benli Technology (301065.SZ) said on the investor interactive platform that the company's existing products and technology have not yet involved the field of synthetic biology.

Gelonghui FinanceMay 8 03:49 ET